Evidence map›Paper›PMID 41823584›Full record

ArticleeLife2026

Readout and delayed transmission of initial afferent V1 activity in decisions about stimulus contrast.

Kieran S Mohr, Simon P Kelly

Abstract read
In one paragraph

Article in eLife, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kieran S MohrCognitive Neural Systems Lab, School of Electrical and Electronic Engineering and UCD Centre for Biomedical Engineering, University College Dublin, Dublin, Ireland.ORCID https://orcid.org/0000-0002-6165-7810
Simon P KellyCognitive Neural Systems Lab, School of Electrical and Electronic Engineering and UCD Centre for Biomedical Engineering, University College Dublin, Dublin, Ireland.ORCID https://orcid.org/0000-0001-9983-3595

Funding

Irish Research Council GOIPD/2024/870Irish Research Council GOIPG/2016/123Wellcome Trust 219572/Z/19/Z
6 · The paper itself

Abstract

Initial afferent activation of V1, indexed by the C1 component of the human VEP, is often considered to be a rudimentary stage of visual processing, operating mostly as a conduit for later stages with limited cognitive penetrability. The full suite of visual analysis entails activity across several visual areas and feedback from later areas to earlier ones. This raises the question of whether the early sensory representation indexed by the C1 is read out for perceptual decisions or whether it is passed over in favour of more advanced representations. To address this question, we asked whether the C1 would predict time-pressured stimulus contrast comparisons independently of physical stimulus conditions, a phenomenon known as choice probability. We found that the C1 did this for a narrow range of response times, indicative of decision readout since the C1 is a transient signal. This effect could not be accounted for by stimulus differences, choice history, or any other choice-predictive signal that we could identify in either the time or frequency domain, either before or after target onset. It also preceded the onset of evidence-dependent decision formation estimated from the centroparietal positivity by tens of milliseconds, together providing an approximate timeline of early evidence readout and its delayed impact on the decision.

Indexed as

Decision MakingEvoked Potentials, VisualVisual CortexVisual PerceptionAdultFemaleHumansMalePhotic StimulationReaction TimeYoung AdultC1decision readouthumanlow-level visionneuroscienceperceptual decision makingspatial visionVEPvisual evoked potential

Identifiers

PMID41823584
PMCPMC12987648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.